Equinor ASA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, dated June 24, 2025, reports on the second tranche of Equinor ASA's 2025 share buy-back program. The tranche was announced on April 30, 2025, with a duration from May 16 to July 21, 2025. The filing details transactions executed between June 16 and June 20, 2025, on the Oslo Stock Exchange (OSE).
Key Financial Metrics
The filing focuses on capital allocation via share repurchases rather than operational financial performance. Key metrics for the reporting period include:
- Shares Purchased (June 16-20): 1,938,262 shares.
- Average Price (June 16-20): NOK 279.0310 per share.
- Total Transaction Value (June 16-20): NOK 540,835,218.73.
- Cumulative Shares Purchased (Tranche to Date): 8,813,206 shares.
- Cumulative Average Price (Tranche to Date): NOK 253.6736 per share.
- Cumulative Transaction Value (Tranche to Date): NOK 2,235,677,447.22.
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
Following the June 16-20 transactions, Equinor ASA's total holdings of own shares increased to 95,575,655, representing 3.42% of the company's share capital (including shares under the share savings program). Excluding the share savings program, the company holds 86,684,533 shares, or 3.10% of share capital.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook regarding future earnings or operational risks. It is a mandatory disclosure pursuant to the EU Market Abuse Regulation and Section 5-12 of the Norwegian Securities Trading Act regarding share buy-back activities.
Investor Verification Checklist
- Verify the total number of shares repurchased under the 2025 program against the authorized limit.
- Confirm the current percentage of treasury shares held relative to total share capital.
- Review the remaining duration of the buy-back tranche (through July 21, 2025) for potential further repurchases.
- Check the average purchase price trend to assess the company's valuation strategy during the tranche.